Contraindications. Parkinson disease, QT prolongation, phaeochromocytoma (metoclopramide), comatose states, severe CNS depression, mechanical obstruction.
Adverse effects. Acute dystonia, akathisia, parkinsonism, tardive dyskinesia, neuroleptic malignant syndrome, sedation, hypotension, hyperprolactinaemia and QT prolongation. Antipsychotics in older adults with dementia raise mortality.
Interactions. Opposition to levodopa and dopamine agonists; additive QT drugs; CNS depressants.
Special groups.
- Pregnancy: metoclopramide and prochlorperazine acceptable short term.
- Breastfeeding: metoclopramide raises prolactin.
- Children: high dystonia risk; avoid.
- Older adults: use the lowest dose.
- Kidney impairment: halve metoclopramide when creatinine clearance is under 60 mL/min.
Monitoring. Abnormal movements, ECG when QT drugs are combined, electrolytes.
Referral and escalation. Acute dystonia: procyclidine 5 to 10 mg intramuscularly or intravenously. Rigidity with fever and altered consciousness suggests neuroleptic malignant syndrome and is an emergency.